Prosecution Insights
Last updated: April 19, 2026

Monte Rosa Therapeutics AG

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18471563 PHARMACEUTICAL COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF A DISEASE OR DISORDER CAUSED BY OR ASSOCIATED WITH ONE OR MORE PREMATURE TERMINATION CODONS HASTINGS, ALISON AZAR 1627 Non-Final OA Sep 21, 2023
18271954 TREATMENT OF MYC-DRIVEN CANCERS WITH GSPT1 DEGRADERS BRAUN, MADELINE E 1624 Non-Final OA Jul 12, 2023

Managing Monte Rosa Therapeutics AG's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month